Correlation Between Pfizer and Arianne Phosphate

Can any of the company-specific risk be diversified away by investing in both Pfizer and Arianne Phosphate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Arianne Phosphate into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Arianne Phosphate, you can compare the effects of market volatilities on Pfizer and Arianne Phosphate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Arianne Phosphate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Arianne Phosphate.

Diversification Opportunities for Pfizer and Arianne Phosphate

-0.27

Correlation Coefficient

Pfizer  Arianne Phosphate

Very good diversification

The 3 months correlation between Pfizer and Arianne is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Arianne Phosphate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arianne Phosphate and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Arianne Phosphate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arianne Phosphate has no effect on the direction of Pfizer i.e., Pfizer and Arianne Phosphate go up and down completely randomly.

Pair Corralation between Pfizer and Arianne Phosphate

Considering the 90-day investment horizon Pfizer is expected to generate 56.38 times less return on investment than Arianne Phosphate. But when comparing it to its historical volatility, Pfizer Inc is 6.13 times less risky than Arianne Phosphate. It trades about 0.01 of its potential returns per unit of risk. Arianne Phosphate is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Arianne Phosphate on December 26, 2024 and sell it today you would earn a total of  1.00  from holding Arianne Phosphate or generate 10.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Arianne Phosphate

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Arianne Phosphate

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Arianne Phosphate are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Arianne Phosphate reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Arianne Phosphate

The main advantage of trading using opposite Pfizer and Arianne Phosphate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Arianne Phosphate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arianne Phosphate will offset losses from the drop in Arianne Phosphate's long position.

The idea behind Pfizer Inc and Arianne Phosphate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.